Plain-English translation of NCT06898203 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a device called SkinScan3D—a specialized 3D camera—to see if it can measure Kaposi sarcoma skin lesions better and more consistently than the standard ruler-based method doctors currently use. This study will compare the two measurement approaches and then test whether the device works reliably in real doctor's offices and clinics where patients are being treated.
Doctors currently measure Kaposi sarcoma lesions by hand with a ruler, which can be inconsistent and time-consuming. A faster, more precise 3D imaging tool could help doctors track how well treatment is working and make better decisions about your care.
You likely qualify if…
You likely don't qualify if…
If you join the first part of the study, your doctor will measure three of your skin lesions using both the standard ruler method and the new 3D camera—this happens at one or more visits. If you join the second part, your doctor will use the standard ruler method for the first three months of your treatment, then switch to using the 3D camera for the remainder of the study period, so researchers can compare how well each method works in real practice.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Kenya
Uganda
Sponsor
Washington University School of Medicine
Collaborators
National Cancer Institute (NCI), Pensievision
Enrollment target
~180 participants
Started
April 2026
Primary completion
November 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas Odeny, MBChB, MPH, PhD
Washington University School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.